Back to Results
First PageMeta Content
Health / Pharmaceutical industry / Pharmacology / European Medicines Agency / Clinical trial / Regulatory requirement / Medical research / Clinical trials registry / Pharmacovigilance / Pharmaceutical sciences / Research / Clinical research


NORDIC COCHRANE CENTRE PRESS RELEASE Brussels, 24 June[removed]EMA’s new policy on access to clinical data:
Add to Reading List

Document Date: 2014-07-16 05:11:00

Open Document

File Size: 591,29 KB

Share Result on Facebook

City

Helsinki / /

Company

AbbVie / EMA / /

Continent

Europe / /

Country

United Kingdom / /

/

Event

Business Partnership / /

Facility

Corporate Europe Observatory / /

IndustryTerm

selected / pharmaceutical industry / pharmaceutical / legal services / not-for-profit health insurance / treatment of major depressive disorder / social security systems / healthcare professionals / health law / pharmaceutical data / privatise pharmaceutical knowledge / /

MedicalCondition

major depressive disorder / sickness / /

Organization

15-World Medical Association / World Trade Organization / Europe International Society of Drug Bulletins / European Parliament / European Medicine Agency / civil society / European Medicines Agency / Medicines Agency / Nordic Cochrane Centre / Internationale / European Commission / EU Commission / European Union / European Institution / /

Person

Emily O'Reilly / Noel Wathion / Glenis Willmott / Harald Kandolf / Guido Rasi / Fergal O Regan / Tonio Berg / Stephano Marino / /

Position

Deputy Head / executive director / Senior Medical Officer / Chief Policy Advisor / Head of Unit / Director / Commissioner / head of legal services / /

Product

Tamiflu / Relenza / /

URL

www.wma.net / www.isdbweb.org / www.haieurope.org / www.aim-mutual.org / /

SocialTag